Scientific Substantiation of the Creation and Prospects for the Development of an Epidemiological Surveillance System for Infection Caused by the Epstein-Barr Virus

Relevance. At the present stage, the Russian Federation does not have a coherent system of supervision and control of infection caused by the Epstein-Barr virus (EBV), while there is an epidemiological problem with this pathology, requiring the development and adoption of a set of adequate management decisions. The goal is to scientifically substantiate the creation of an epidemiological surveillance system (ES) for EBV -infection in Russia. Materials and methods. Based on the results of previous studies, an assessment of the manifestations of the epidemic process of EBV infection and measures aimed at each of its links was carried out. Results. The structure and content of the system of epidemiological surveillance of EBV infection are presented. Conclusion. To implement and improve the effectiveness of EBV-infection control, it is necessary to adjust existing and develop new regulatory and methodological documents that allow introducing: a standard definition of the case of EBV-infection and new approaches to accounting and registration; studies of nasopharyngeal smear material for the presence of EBV genetic material as part of the monitoring of influenza and ARVI pathogens; algorithms for the examination of patients with diagnoses that do not exclude the presence of active EBV-infection, as well as organ, tissue and cell donors with the determination of a complex of nonspecific immunological markers (neopterin, melatonin, C-reactive protein, ALT); standard operating procedures for medical professionals for the identification and isolation of patients with active EBV-infection, clinical and laboratory diagnostics, registration and accounting, the use of personal protective equipment and nonspecific immunoprophylaxis. Also, improving the control of EBVinfection is impossible without continuing scientific research; professional training of medical workers on the clinic, diagnosis, epidemiology and prevention of EBV-infection; development of modern visual methods and means of informing the population about the clinic and prevention of EBV-infection. 

1. Mindlina A.Ja. Improving information technologies and software is a necessary component of optimizing the epidemiological surveillance system. Medicinskij al’manah. 2012;3(22):47–50 (In Russ.).

2. Aksjutina L.P. Epidemiological surveillance as the basis of a modern methodological and scientific approach to the analysis of the epidemiological situation of tuberculosis. Bjulleten’ VSNC SO RAMN. 2012;1(83):86–92 (In Russ.).

3. Simonova E.G. The current stage of development of epidemiological surveillance and prospects for its improvement. Jepidemiologija i vakcinoprofilaktika. 2017;16(4):4–7 (In Russ.).

4. Asratjan A.A., Simonova E.G., Kazarjan S.M., Orlova O.A., Il›enkina K.V., Raichin S.R., et al.. Epstein-BARR viral infection: the current situation and clinical and epidemiological features in women of childbearing age and newborns. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2017;6:25–31 (In Russ.).

5. Mardanly S.G., Simonova E.G., Simonov V.V. Herpesvirus infections: etiology and pathogenesis, clinic and laboratory diagnostics, epidemiology and prevention. Orehovo-Zuevo, 2020 (In Russ.).

6. Demina O. I., Tihomirov D. S., Chebotarjova T.A., Mazankova L.N., Tupoleva T.A. Clinical significance of virological methods for verifying the etiology of infectious mononucleosis. Detskie infekcii. 2020;2:29–37 (In Russ.).

7. Solomay T.V. Long-term dynamics of morbidity and territorial spread of infectious mononucleosis. Zdravoohranenie Rossijskoj Federacii. 2019;63(4):186–192 (In Russ.). doi: 10.18821/0044-197X-2019-63-4-186-192

8. Anganova E.V., Il’ina S.V., Kozlova I.V., Malov I.V., Ogarkov O.B., Savilov E.D., et al. General epidemiology. Kurs lekcij / Moskva, 2020 (In Russ.).

9. Edwards R.H., Seillier-Moiseiwitsch F., Raab-Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein–Barr virus strains. Virology, 1999;261(1):79–95. doi: 10.1006/viro.1999.9855

10. Senjuta N.B., Ignatova A.V., Lomaja M.V., Goncharova E.V., Shherbak L.N., Dushen’kina T.E., et al. Epstein–BARR virus in patients with nasopharyngeal cancer and healthy individuals in two geographically different regions of Russia. Infekcija i immunitet. 2017;7(1):41–50 (In Russ.). doi: 10.15789/2220-7619-2017-1-41-50

11. Senjuta N.B., Smirnova K.V., Diduk S.V., Goncharova E.V., Shherbak L.N., Gurcevich V.Je. Structural and functional characteristics of the LMP1 oncogene in patients with tumors associated and not associated with Epstein—Barr virus. Molekuljarnaja genetika, mikrobiologija i virusologija. 2016;2:71–75 (In Russ.). doi 10.18821/0208-0613-2016-34-2-71-75

12. Smirnova K.V., Senjuta N.B., Botezatu I.V., Dushen’kina T.E., Lubenskaja A.K., Frolovskaja A.A., et al. Epstein–BARR virus in ethnic Tatars: infection and sequence variants of the LMP1 oncogene. Uspehi molekuljarnoj onkologii 2018;5(3):65–74 (In Russ.). doi: 10.17650/2313-805X-2018-5-3-65-74

13. Solomay T.V., Semenenko T.A., Bloh A.I. The prevalence of antibodies to the Epstein-BARR virus in different age groups of the population of Europe and Asia: a systematic review and meta-analysis. Zdravoohranenie Rossijskoj Federacii. 2021;65(3):276–286 (In Russ.). https://doi.org/10.47470/0044-197X-2021-65-3-276-286

14. Solomay T.V., Semenenko T.A. Prevention of transmission in medical organizations of infection caused by the Epstein-Barr virus (literature review). Gigiena i sanitarija. 2021; 100(1):36–41 (In Russ.). https://dx.doi.org/10.47470/0016-9900-2021-100-1-36-41

15. Solomay T.V., Semenenko T. A., Filatov N. N., Kostinov M.P., Il’ina N.I. Epstein-Barr virus: vaccine development. Immunologija. 2020;41(4):381–390 (In Russ.). DOI: 10.33029/0206-4952-2020-41-3-381-390

16. Avgil M, Ornoy A. Virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol. 2006;21(4):436–45. doi: 10.1016/j. reprotox.2004.11.014.

17. Dunmire SK, Grimm JM, Schmeling DO, Balfour HH, Hogquist KA. The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events. PLoS Pathog. 2015;11: e1005286.

18. Osipova L.S. Features of the course and treatment of infection caused by the Epstein-Barr virus. Medicina segodnja. 2011;18(387):6–7 (In Russ.).

19. Solomay T.V., Semenenko T.A., Karazhas N.V., Rybalkina T.N., Kornienko M.N., Bosh’jan R.E., et al. Risk assessment of infection with herpesviruses during transfusion of donor blood and its components. Health risk analysis. 2020;2:135–142 (In Russ.). doi: 10.21668/health.risk/2020.2.15.eng

20. Mihneva S.A., Kuhtevich E.V., Grishina Ju.Ju., Popova T.I., Martynov Ju.V. Differential diagnosis of Epstein-BARR viral mononucleosis and mononucleoside syndrome in HIV infection in adults at the prehospital stage. Infekcionnye bolezni: Novosti. Mnenija. Obuchenie. 2021;10(1):39–45 (In Russ.) DOI: https://doi.org/10.33029/2305-3496-2021-10-1-39-45

21. Walling DM, Flaitz CM, Nichols CM. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis. 2003;188(6):883–890. doi: 10.1086/378072.

22. Solomay T.V., Semenenko T.A., Filatov N.N., Kolbutova K.B., Olejnikova D.Ju., Karazhas N.V. The role of children and adults as a reservoir of pathogens during the seasonal rise in the incidence of upper respiratory tract infections. Detskie infekcii. 2020;19(3):5–11 (In Russ.). doi:10.22627/2072-8107-2020-19-3-5-11

23. Tachikawa R, Tomii K, Seo R, Nagata K, Otsuka K, Nakagawa A, et al. Detection of herpes viruses by multiplex and real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with acute lung injury or acute respiratory distress syndrome. Respiration. 2014;87(4):279–86. doi: 10.1159/000355200.

24. Solomay T.V., Semenenko T.A., Filatov N.N., Vedunova S.L., Lavrov V.F., Smirnova D.I., Grachjova A.V., Fajzuloev E.B. Reactivation of infection caused by Epstein–BARR virus (Herpesviridae: Lymphocryptovirus, HHV-4), against the background of COVID-19: epidemiological features. Voprosy virusologii. 2021;66(2):152–161 (In Russ.). doi: 10.36233/0507-4088-40

25. Solomay T.V., Semenenko T.A. Viral hepatitis B, C and infectious mononucleosis: epidemiological similarities and differences. Voprosy virusologii. 2020;65(1):27–34 (In Russ.). doi: 10.36233/0507-4088-2020-65-1-27-34

26. Solomay T.V. Semenenko T.A., Ivanova M.Ju. The role of Epstein-Barr viral infection and hepatitis B and C in liver pathology. Voprosy virusologii. 2019;64(5):215–220 (In Russ.). doi: https://doi.org/10.36233/0507-4088-2019-64-5-215-220

27. Drozdova M.V., Karelin A.V., Larionova S.N., Bykova A.V., Garifullin M.M. Possible reasons for the absence of pharyngeal tonsil involution in adolescents. Rossijskaja otorinolaringologija. 2019;18(4):39–43 (In Russ.). doi: 10.18692/1810-4800-2019-4-39-43

28. Karlıdağ T, Bulut Y, Keleş E, Alpay HC, Seyrek A, Orhan İ, Karlıdağ GE, Kaygusuz İ. Presence of herpesviruses in adenoid tissues of children with adenoid hypertrophy and chronic adenoiditis. Kulak Burun Bogaz Ihtis Derg. 2012;22(1):32–7. doi: 10.5606/kbbihtisas.2012.006.

29. Gonzalez-Lucano LR, Vasquez-Armenta GV, Pereira-Suarez AL, Ramirez-de Arellano A, Ramirez-de Los Santos S, Lopez-Pulido EI. Prevalence of Epstein-Barrvirus DNA in tonsillar tissue from patients with chronic tonsillitis in Mexican population. J Infect Dev Ctries. 2019;13(8):764–767. doi: 10.3855/jidc.11424.

30. Solomay T.V., Semenenko T.A., Filatov N.N., Habazov R.I., Dupik N.V., Dundua D.P., et al. Risk razvitija boleznej sistemy krovoobrashhenija na primere narushenij ritma serdca u pacientov s serologicheskimi markerami Jepshtejna-Barr virusnoj infekcii. Analiz riska zdorov’ju. 2021;3:150–159 (In Russ.). DOI: 10.21668/health.risk/2021.3.15

31. Frølund UC, Nielsen SL, Hansen PB. Burkitt lymphoma is a highly malign tumour with a doubling time of twenty-four hours. Ugeskr Laeger. 2011;173(43):2714–8.

32. Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol. 2019; 208(5):573–583. doi: 10.1007/s00430-018-0570-1.

33. Jugan Ja.L., Sockaja Ja.A. The effect of a combination of modern drugs on the level of circulating immune complexes in patients with non-alcoholic steatohepatitis on the background of neurocirculatory dystonia, after infectious mononucleosis. Klinicheskaja medicina Kazahstana. 2013;4(30):52–59 (In Russ.).

34. Fretzayas A., Moustaki M., Attilakos A., Brozou T., Nicolaidou P. Acalculous cholecystitis or biliary dyskinesia for Epstein-Barr virus gallbladder involvement? Prague Med Rep. 2014;115(1–2):67–72. doi: 10.14712/23362936.2014.7.

35. Knöpfel N, Noguera-Morel L, Latour I, Torrelo A. Viral exanthems in children: A great imitator. Clin Dermatol. 2019;37(3):213–226. doi: 10.1016/j.clindermatol.2019.01.009.

36. Fatkullina G.R., Anohin V.A. Laterothoracic exanthema and herpetic infections in children. Rossijskij vestnik perinatologii i pediatrii. 2019;64:(5):235–240 (In Russ.). DOI: 10.21508/1027–4065–2019–64–5–235–240

37. Bir T.V., Drobunina E.V., Petrenko E.P. Difficulties in the diagnosis of infectious mononucleosis. Zdravoohranenie Jugry: opyt i innovacii. 2020;1:40–42 (In Russ.)

38. Kanakry J, Ambinder R. The biology and clinical utility of EBV monitoring in blood. Curr Top Microbiol Immunol. 2015;391:475–99. doi: 10.1007/978-3-319-22834-1_17.

39. Cederberg LE, Rabinovitch MD, Grimm-Geris JM, Schmeling DO, Filtz EA, Condon LM, Balfour HH Jr. Epstein-Barr Virus DNA in Parental Oral Secretions: A Potential Source of Infection for Their Young Children. Clin Infect Dis. 2019;68(2):306–312. doi: 10.1093/cid/ciy464.

40. Sengar M, Chorghe S, Jadhav K, Singh S, Laskar SG, Pai P, et al. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine. Head Neck. 2016;38 Suppl 1:E1666–73. doi: 10.1002/hed.24297.

41. Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE. Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. J Clin Microbiol. 2011;49(7):2435–9. doi: 10.1128/JCM.02206-10.

42. Naumenko V, Tyulenev Y, Kurilo L, Shileiko L, Sorokina T, Evdokimov V, Yakovleva V, Kovalyk V, Malolina E, Kulibin A, Gomberg M, Kushch A. Detection and quantification of human herpes viruses types 4–6 in sperm samples of patients with fertility disorders and chronic inflammatory urogenitaltract diseases. Andrology. 2014;2(5):687–94. doi: 10.1111/j.2047-2927.2014.00232.x.

43. Kuz’mina G.V., Demenchuk M.Ju., Kochetko K.B., Fedoseeva I.V., Levit R.M. Persistence of Epstein-BARR virus in the gastric mucosa in chronic gastroduodenitis in children. Infekcija i immunitet. 2012;1–2:286 (In Russ.).

44. Semenenko T.A., Anan’ina Ju.V., Boev B.V., Gincburg A.L. Banks of biological resources in the system of fundamental epidemiological and clinical research. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta. 2011;5:5–9 (In Russ.).

45. Solomay T.V., Semenenko T.A., Karazhas N.V., Rybalkina T.N., Veselovskij P.A., Pul’nova N.L., et al. Features of changes in the indicators of the immune status of persons with active and latent forms of herpesvirus infections. Permskij medicinskij zhurnal. 2021;38(1):46–63 (In Russ.). doi: 10.17816/pmj38146%63

46. Solomay T.V., Semenenko T.A., Gotvjanskaja T.P., Konopleva M.V., Davtjan S.A., Suslov A.P., Il’ina N.I. The role of C-reactive protein, neopterin and melatonin in the diagnosis of Epstein-BARR virus infection. Immunologija. 2021; 42 (5):502–510 (In Russ.).

47. Simonova E.G., Sergevnin V.I. Pre-epidemic diagnostics in the system of risk-oriented epidemiological surveillance of infectious diseases. Epidemiology and Vaccinal Prevention. 2018;17(5):31–37 (In Russ.). https://doi.org/10.31631/2073-3046-2018-17-5-31-37

48. Solomay T.V., Semenenko T.A., Isaeva E.I., Vetrova E.N., Chernyshova A.I., Romenskaja Je.V., Karazhas N.V. COVID-19 and the risk of reactivation of herpesvirus infection. Aktual’nye voprosy. 2021;11(2):55–62 (In Russ.). doi: 10.18565/epidem.2021.11.2.55–62

49. Solomay T.V., Kulikova M.M. Awareness of doctors about the infection caused by the Epstein-Barr virus. Sanitarnyj vrach. 2019;7:30–41 (In Russ.).

50. Solomay T.V., Isaeva E.I., Vetrova E.N., Chernyshova A.I., Semenenko T.A., Panteleeva L.G. Evaluation of the effectiveness of chemical disinfection agents against Epstein-BARR virus. Dezinfekcionnoe delo. 2021;3:40–48 (In Russ.). DOI: 10.35411/2076-457X-2021-3-40-48

51. Solomay T.V., Semenenko T.A., Kuzin S.N., Akimkin V.G. Territorial features of the epidemic process of infection caused by the Epstein–Barr virus. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2021;10(4):81–9. (In Russ.). DOI: https://doi.org/10.33029/2305-3496-2021-10-4-81-89 .